The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! #quarantitties / X

Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! / X

Artivion strengthens On-X heart valve data with real-world study

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! #quarantitties / X

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: Approved! / X

Artivion Announces Publication of On-X® Mitral Heart Valve PROACT Study Results in The Annals of Thoracic Surgery

Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress

Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium

Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve‐Induced Thrombin Generation

The Boobs Approver™ - 1️⃣4️⃣3️⃣k on X: .@Cabiriaxxx has been approved! / X